Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupSarcomasDiseaseGiant Cell Tumor of the BoneSubgroupICD10D48.0MeSHGiant Cell Tumor of BoneSequenceDENO120, Giant Cell Tumor of the Bone, C1 (PID925) -|- C2+ (PID927)ChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceDenosumabSupportive substanceDenosumabSupportive substanceDenosumabSupportive substanceDenosumabNo. Substances1Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentiondisease controlRisksAnemia Hb below 8g/dlBone PainHypocalcemiaHypophosphatemiaInfectionsOsteonecrosis of the Jaw only studiesPublicationAuthorChawla SDiseaseRiesenzelltumor des Knochens, Alter > 12 Jahre, Karnofsky > 50OriginSarcoma Oncology Center, Santa Monica, CA, USAProtocols in Revision 2 protocols foundProtocols under revision.Denosumab 120, Giant Cell Tumor of the Bone, Cycle 1 (PID925 V1.0)Denosumab 120, Giant Cell Tumor of the Bone, Cycle 2+ (PID927 V1.0)
